Inventor

Georg Fertig

Inventor

Penzberg, DE

Overview

2004–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 37 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%

C07KPeptides21%

A61KPreparations for medical, dental or toiletry purposes20%

C07DHeterocyclic compounds10%

C12NMicroorganisms or enzymes7%

C07CAcyclic or carbocyclic compounds5%

G01NInvestigating or analysing materials by determining their chemical or physical properties3%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%

PatentTitleYear

10,718,762Cellular based fret assay for the determination of simultaneous binding2020 10,336,830Antibodies against human CSF-1R and uses thereof2019 10,287,358Antibodies against human CSF-1R and uses thereof2019 10,287,352Bispecific antibodies specific for PD1 and TIM32019 10,077,314Antibodies against human CSF-1R and uses thereof2018 10,072,087Antibodies against human CSF-1R and uses thereof2018 10,030,073Antibodies against human CSF-1R and uses thereof2018 10,023,643Antibodies against human CSF-1R and uses thereof2018 9,988,458Antibodies against human CSF-1R and uses thereof2018 9,951,139Antibodies against human CSF-1R and uses thereof2018 9,951,140Antibodies against human CSF-1R and uses thereof2018 9,879,085'Antibodies against human CSF-1R and uses thereof'2018 9,663,580'Antibodies against human CSF-1R and uses thereof'2017 9,624,302'Nucleic acids encoding antibodies against human CSF-1R'2017 9,617,342'Nucleic acids encoding antibodies against human CSF-1R and uses thereof'2017 9,499,625'Antibodies against human CSF-1R and uses thereof'2016 9,499,626'Antibodies against human CSF-1R and uses thereof'2016 9,499,624'Antibodies against human CSF-1R and uses thereof'2016 9,309,319'Antibodies against human IL33R and uses thereof'2016 9,221,910'Antibodies against human CSF-1R'2015 9,169,323'Antibodies against human CSF-1R'2015 8,999,327'Antibodies against human CSF-1R and uses thereof'2015 8,900,581'Antibodies against human CSF-1R and uses thereof'2014 8,883,159'Antibodies against CDCP1 for the treatment of cancer'2014 8,785,153'Antibodies against human IL33R and uses thereof'2014 7,759,071'Determination of apoptotic products in tumor patients undergoing therapy'2010 7,638,553'Hydroxamates, their manufacture and use as pharmaceutical agents'2009 7,501,451'Mono-acylated o-phenylendiamines derivatives'2009 7,423,060'Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors'2008 7,396,944'Thiophene derivatives, their manufacture and use as pharmaceutical agents'2008 7,229,772'Detection of apoptotic products'2007 7,208,491'N-monoacylated o-phenylenediamines'2007 7,173,060'Oxime derivatives and their use as pharmaceutically active agents'2007 7,098,247'Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives'2006 7,071,219'Mono-acylated o-phenylendiamines derivatives'2006 6,946,471'2-(2,6-Dichlorophenyl)-Diarylimidazoles'2005 6,790,852'2-(2,6-dichlorophenyl)-diarylimidazoles'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2020Patents assigned to HOFFMANN LA ROCHE (32)· patent assignee history

2004–2020Based in Penzberg, DE· patent location history

2014–2015Patents assigned to FERTIG GEORG (5)· patent assignee history

2014–2015Patents assigned to KALUZA KLAUS (4)· patent assignee history

2014–2015Patents assigned to SEEBER STEFAN (4)· patent assignee history

2015Patents assigned to FIDLER ALEXANDER (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
HOFFMANN LA ROCHE	32	2004–2020
FERTIG GEORGself	5	2014–2015
KALUZA KLAUS	4	2014–2015
SEEBER STEFAN	4	2014–2015
FIDLER ALEXANDER	3	2015

Locations

Location	Patents	Span
Penzberg, DE	37	2004–2020